Reviewing proceedings of the II International Conference “Metabolic Syndrome and Dyslipidemia”, New York: how to adapt largeD scale studies' results to realDworld clinical settings in Russia?

1. Eschwege E. The dysmetabolic syndrome, insulin resistance and increased cardiovascular morbidity and mortality in type 2 diabetes: etiological factors in the development of CV complications//Diabetes Metab. 2003; 29: 6S19-6S27

2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III)//JAMA. 2001;285:2486-97

3. Balkau B. Epidemiology of the metabolic syndrome and the RISC study//Eur. Heart J. 2005; 7:D6-D9

4. Despres J.P., Lemieux I., Prud'homme D. Treatment of obesity: need to focus on high risk abdominally obese patients//BMJ 2001; 322: 716-20

5. Kannel W., Larson M. Long-term epidemiologic prediction of coronary disease. The Framingham experience//Cardiology 1993; 82: 137-52.

6. Assmann G., Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease//Am. Heart. J. 1988; 116: 1713-24.

7. Modan M., Halkin H., Lusky A., Segal P., Fusch Z., Chetrit A. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL and HDL levels. A population-based study//Arteriosclerosis, 1988; 8: 227-236.

8. Новые Европейские рекомендации по профилактике и лечению сердечно-сосудистых заболеваний//Доказательная кардиология 2003; 2:34-36

9. Taylor A.J., Sullenberger L.E., Lee H.J. et al.//Circulation 2004;110:3512-7

10. Valensi P. All in one. Monde Moderne (France) 2004: p 71-110, 184-209

11. Fruchart J.C., Staels В., Duriez P. PPARS, metabolic disease and atherosclerosis//Pharmacol. Res 2001; 44: 345-52.

12. Мамедов М.Н. Выбор антигипертензивной терапии у больных с метаболическим синдромом: клиническая эффективность Энама//Новые лекарственные препараты 2005; стр 52-59

13. Чазова И.Е., Мычка В.Б. Метаболический синдром//Из-во Media Medica, Москва 2004: стр. 36-47

14. Мамедов М.Н. Руководство по диагностике и лечение метаболического синдрома//Из-во Мультипринт, Москва 2004: стр. 44-49

15. American Diabetes Association. Diabetic dyslipidemia management order of priorities for treatment//Diabetes Care 2004; 27 (Suppll): S28-S71